Send in your spam and get the offenders listed
Create a rule in outlook or simply forward the spam you receive to firstname.lastname@example.org
AUDIENCE: Risk Manager, Nursing, Anesthesiology, Otolaryngology, Surgery, Critical Care Medicine
ISSUE: Medtronic announced that on May 8, 2015, it began notifying hospitals and distributors worldwide that affected lots of its Covidien Shiley tracheostomy tubes were formed with a wider-angle bend than standard models manufactured after November 29, 2012. The company initiated the field action following customer complaints that included reports of 12 serious patient injuries, such as breathing difficulties that impacted oxygen levels, immediately upon tube placement or discomfort. Replacement of the tracheostomy tube with product manufactured prior to November 29, 2012 addressed the patient breathing difficulty or discomfort.
The recall includes specific lots from eight product lines that were manufactured after November 29, 2012. See the Press Release for detailed product recall information.
BACKGROUND: A Shiley tracheostomy tube is put through a patient's trachea (windpipe) during a tracheostomy procedure to help provide an airway and facilitate the ability to breathe.
RECOMMENDATION: Customers and distributors who have provided the recalled Shiley tracheostomy tubes to a homecare provider or patient must notify the primary care physician and the homecare provider that these products should be discontinued from use and returned. If one of the recalled products is currently in use in a homecare patient, and the patient is not experiencing any discomfort, breathing difficulties or any other issues related to the tube, it is recommended that the patient's physician evaluate the continued use. If the physician advises leaving the tracheostomy tube in place, the tube must be replaced with an alternate device at the next tube exchange.
Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:
Read the MedWatch safety alert, including a link to the press release, at: